$SGEN News Article - Astellas and Seagen Announce Positive Topline Results from Second Cohort of Patients in Phase 2 Pivotal Trial of PADCEV (enfortumab vedotin-ejfv) in Advanced Urothelial Cancer
https://marketwirenews.com/news-releases/aste...69721.html